European Society of Surgical Oncology
0435.191.191 · rovalta.com · 28/09/2026
European Society of Surgical Oncology
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOEuropean Society of Surgical Oncology is a Non-profit organization incorporated in 1988. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Woluwe-Saint-Lambert. It employs on average 6,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0435.191.191
- Incorporation
- 18/03/1988
- Legal form
- Non-profit organization
- Registered office
- Clos Chapelle-aux-Champs 30 box 1.30
1200 Woluwe-Saint-Lambert · BruxellesSee on map - Latest accounts
- 31/12/2025
- Average workforce
- 6,3 ETP
Joint committees (1)
- 32902
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 1,2 M € | -0.6% | 1,2 M € | +57.7% | 777 k € | +6.8% | 727,2 k € | +39.8% | 520,2 k € |
| EBITDA | 140,8 k € | -59.8% | 350,6 k € | +350% | 77,9 k € | -48.5% | 151,4 k € | +39.4% | 108,6 k € |
| Operating result | 130 k € | -62.1% | 342,7 k € | +345% | 77 k € | -49.1% | 151,3 k € | +40.6% | 107,6 k € |
| Net result | 118,9 k € | -64.0% | 330,6 k € | +215% | 105 k € | -12.6% | 120,1 k € | +42.2% | 84,4 k € |
| Balance sheet | |||||||||
| Equity | 2,9 M € | +4.3% | 2,8 M € | +13.6% | 2,4 M € | +4.5% | 2,3 M € | +5.5% | 2,2 M € |
| Total assets | 3,3 M € | +2.4% | 3,2 M € | +20.6% | 2,7 M € | +6.6% | 2,5 M € | +3.7% | 2,4 M € |
| Cash | 557,8 k € | -34.7% | 854,7 k € | +1165% | 67,6 k € | -87.2% | 529,5 k € | +42.1% | 372,7 k € |
| Debts | 194,5 k € | -51.2% | 398,9 k € | +119% | 182,3 k € | +13.9% | 160 k € | +38.1% | 115,9 k € |
| Other | |||||||||
| Workforce | 6,3 ETP | +26.0% | 5,0 ETP | +25.0% | 4,0 ETP | 0.0% | 4,0 ETP | +29.0% | 3,1 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/202513 active · 10 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ashutosh Kothari | Director03/10/2024 → 05/11/2026 | |
Geerard Beets | Chairman of the board of directors20/10/2022 → 05/11/2026Director11/10/2018 → 20/10/2026ended | |
Giuseppe Francesco Catanuto | Director22/10/2022 → 05/11/2026 | |
Isabel Rubio Rodriguez | Vice-chairman of the board of directors03/10/2024 → 05/11/2026Chairman of the board of directors20/10/2022 → 20/10/2026endedDirector11/10/2018 → 20/10/2022ended | |
Laura Lorenzon | Director03/10/2024 → 05/11/2026 | |
Malik Hassan | Vice-chairman of the board of directors03/10/2024 → 05/11/2026Director11/10/2018 → 20/10/2026ended | |
Marco Fiore | Director03/10/2024 → 05/11/2026 | |
Michel Rivoire | Trésorier du Conseil d'Administration03/10/2024 → 05/11/2026Director11/10/2018 → 20/10/2026ended | |
Muhammad Khan | Director03/10/2024 → 05/11/2026 | |
Nada Santrac | Director03/10/2024 → 05/11/2026 | |
Stefan Stättner | Director22/10/2022 → 05/11/2026 | |
Wim Ceelen | Secrétaire du Conseil d'Administration03/10/2024 → 05/11/2026Director15/06/2020 → 31/10/2024ended | |
Yvonne Schrage | Director03/10/2024 → 05/11/2026 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Carmela Isabel Caballero | Director20/10/2022 → 20/10/2026 | |
Domenico D'Ugo | Vice-chairman of the board of directors20/10/2022 → 20/10/2026 |
Other companies at this address
Clos Chapelle-aux-Champs 30 1200 Woluwe-Saint-Lambert| Company | CBE no. |
|---|---|
ABDA LILLY● Active | 0679.918.728 |
Acar'Up● Active | 0567.583.523 |
ACCELERATE● Active | 0733.539.041 |
ADGN● Active | 0682.872.377 |
ALLERINVEST● Active | 0644.917.069 |
astrohealth foundation● Active | 1011.965.663 |
BELBABY● Active | 0737.992.826 |
| 0457.785.857 | |
| 0414.282.743 | |
BIOPHARMATEK● Active | 0675.688.340 |
BRUSSELS LIFE SCIENCE INCUBATOR● Active | 0899.602.447 |
Cancer Drug Development Forum● Active | 0738.523.752 |
CELLTEST● Active | 0794.359.823 |
CENTRE CHAPELLE-AUX-CHAMPS● Active | 0460.875.209 |
| 0892.776.419 | |
| 0409.122.244 | |
| 0424.199.410 | |
| 0463.116.404 | |
Data for Healthcare Improvement● Active | 1008.075.864 |
| 0475.491.624 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/06/2026 | 29/09/2025 | 11/07/2024 | 05/07/2023 | 01/07/2022 | 21/09/2021 |
| General meeting | 02/06/2026 | 07/06/2025 | 07/06/2024 | 20/06/2023 | 04/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/06/2026 | 26/06/2026 | French | |
| Abridged model | 31/12/2024 | 07/06/2025 | 29/09/2025 | French | |
| Abridged model | 31/12/2023 | 07/06/2024 | 11/07/2024 | French | |
| Abridged model | 31/12/2022 | 20/06/2023 | 05/07/2023 | French | |
| Abridged model | 31/12/2021 | 04/06/2022 | 01/07/2022 | French | |
| Abridged model | 31/12/2020 | 25/06/2021 | 21/09/2021 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202513 active · 10 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ashutosh Kothari | Director03/10/2024 → 05/11/2026 | |
Geerard Beets | Chairman of the board of directors20/10/2022 → 05/11/2026Director11/10/2018 → 20/10/2026ended | |
Giuseppe Francesco Catanuto | Director22/10/2022 → 05/11/2026 | |
Isabel Rubio Rodriguez | Vice-chairman of the board of directors03/10/2024 → 05/11/2026Chairman of the board of directors20/10/2022 → 20/10/2026endedDirector11/10/2018 → 20/10/2022ended | |
Laura Lorenzon | Director03/10/2024 → 05/11/2026 | |
Malik Hassan | Vice-chairman of the board of directors03/10/2024 → 05/11/2026Director11/10/2018 → 20/10/2026ended | |
Marco Fiore | Director03/10/2024 → 05/11/2026 | |
Michel Rivoire | Trésorier du Conseil d'Administration03/10/2024 → 05/11/2026Director11/10/2018 → 20/10/2026ended | |
Muhammad Khan | Director03/10/2024 → 05/11/2026 | |
Nada Santrac | Director03/10/2024 → 05/11/2026 | |
Stefan Stättner | Director22/10/2022 → 05/11/2026 | |
Wim Ceelen | Secrétaire du Conseil d'Administration03/10/2024 → 05/11/2026Director15/06/2020 → 31/10/2024ended | |
Yvonne Schrage | Director03/10/2024 → 05/11/2026 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Carmela Isabel Caballero | Director20/10/2022 → 20/10/2026 | |
Domenico D'Ugo | Vice-chairman of the board of directors20/10/2022 → 20/10/2026 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates28/02/2025OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates18/08/2023DEMISSIONS, NOMINATIONS
- Mandates15/03/2021DEMISSIONS, NOMINATIONS
- Mandates08/03/2019SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates14/08/2017DEMISSIONS, NOMINATIONS
- Mandates03/04/2015DEMISSIONS, NOMINATIONS
- Mandates10/06/2009DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Clos Chapelle-aux-Champs 30 bte 1.30, 1200 Woluwe-Saint-LambertCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00202393 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| European Society of Surgical OncologyCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00202393 |
Events
- 2025Annual accounts 2025118,9 k €↓
- 2024Annual accounts 2024330,6 k €↑
- 2023Annual accounts 2023105 k €↓
- 2022Annual accounts 2022120,1 k €↑
- 2021Annual accounts 202184,4 k €↑
- 2020Annual accounts 2020-140 k €
- 18/03/1988IncorporationNon-profit organization